Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome Bouzas, Cristina Riquelme Gallego, Blanca Metabolic syndrome Glucagon-like peptide 1 agonists GLP-1RA 4-dipeptidyl peptidase inhibitors DPP-4I 2023-07-18T10:19:59Z 2023-07-18T10:19:59Z 2023-03-17 journal article C. Bouzas et al. Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome. Biomedicine & Pharmacotherapy 161 (2023) 114561[https://doi.org/10.1016/j.biopha.2023.114561] https://hdl.handle.net/10481/83838 10.1016/j.biopha.2023.114561 eng http://creativecommons.org/licenses/by-nc-nd/4.0/ open access Attribution-NonCommercial-NoDerivatives 4.0 Internacional Elsevier